Skip to main content
Tech.euFundingExplorerBeta

Spineart

Spineart is a medical device company that develops and manufactures solutions for motion preservation, posterior fixation, interbody fusion, and biologics.

Spineart has raised €124M across 4 funding rounds from 3 investors, most recently a round in Oct 2025. Based in Meyrin, Switzerland; founded 2005; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€124M
€123,841,460
Funding rounds
4
Investors
3
distinct backers
Active since
2016-09
latest 2025-10

Funding by year

EUR raised per year
Spineart — funding by year — interactive chart.
Data table
Spineart — funding by year
2016€30M
2020€46M
2024€21M
2025€27M

Signals

High confidence
Raise-next likelihood46
base rate 30% for Other
  • ▲ In typical raise window
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood16
base rate 11% (2+ rounds)
  • ▲ €100M+ raised
  • ▲ 4 rounds raised
  • ▼ Old (21y) — past typical exit age
  • ▲ Recently backed by strong-exit-track investors

Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

4 rounds
DateStageAmountInvestors
2025-10-01Other€27MEGS Beteiligungen (EGSB),GIMVView deal →
2024-03-19Debt€21M—View deal →
2020-10-06Other€46M—View deal →
2016-09-01Growth/Late€30MGIMVView deal →

Similar companies

same sector or country

Global coverage: FundingData